Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF‐β
暂无分享,去创建一个
[1] D. Bigner,et al. Transforming Growth Factor-β-mediated p15INK4BInduction and Growth Inhibition in Astrocytes Is SMAD3-dependent and a Pathway Prominently Altered in Human Glioma Cell Lines* , 1999, The Journal of Biological Chemistry.
[2] J. Massagué,et al. Myc Downregulation by Transforming Growth Factor β Required for Activation of the p15Ink4b G1 Arrest Pathway , 1999, Molecular and Cellular Biology.
[3] R. Tjian,et al. Purification of transcription cofactor complex CRSP. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[5] W. Wang,et al. Cooperative Binding of Smad Proteins to Two Adjacent DNA Elements in the Plasminogen Activator Inhibitor-1 Promoter Mediates Transforming Growth Factor β-induced Smad-dependent Transcriptional Activation* , 1999, The Journal of Biological Chemistry.
[6] K. Miyazono,et al. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. , 1999, Science.
[7] Robert Tjian,et al. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1 , 1999, Nature.
[8] K. Miyazono,et al. Drosophila dSmad2 and Atr‐I transmit activin/TGFβ signals , 1999, Genes to cells : devoted to molecular & cellular mechanisms.
[9] E. Lai,et al. FAST-2 Is a Mammalian Winged-Helix Protein Which Mediates Transforming Growth Factor β Signals , 1999, Molecular and Cellular Biology.
[10] R. Derynck,et al. Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.
[11] S. Friedman,et al. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. , 1998, The Journal of biological chemistry.
[12] S. Friedman,et al. Transcriptional Activation of Transforming Growth Factor β1 and Its Receptors by the Kruppel-like Factor Zf9/Core Promoter-binding Protein and Sp1 , 1998, The Journal of Biological Chemistry.
[13] A. Roberts,et al. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] Xing Shen,et al. TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. , 1998, Molecular biology of the cell.
[15] T. Gelehrter,et al. Smad4/DPC4 and Smad3 Mediate Transforming Growth Factor-β (TGF-β) Signaling through Direct Binding to a Novel TGF-β-responsive Element in the Human Plasminogen Activator Inhibitor-1 Promoter* , 1998, The Journal of Biological Chemistry.
[16] H. Lodish,et al. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. , 1998, Genes & development.
[17] J. Graff,et al. Smad3 Mutant Mice Develop Metastatic Colorectal Cancer , 1998, Cell.
[18] J. Massagué,et al. Physical and Functional Interaction of SMADs and p300/CBP* , 1998, The Journal of Biological Chemistry.
[19] Yigong Shi,et al. Crystal Structure of a Smad MH1 Domain Bound to DNA Insights on DNA Binding in TGF-β Signaling , 1998, Cell.
[20] K. Miyazono,et al. Role of p300, a transcriptional coactivator, in signalling of TGF‐β , 1998, Genes to cells : devoted to molecular & cellular mechanisms.
[21] R. Derynck,et al. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.
[22] M. Whitman. Smads and early developmental signaling by the TGFbeta superfamily. , 1998, Genes & development.
[23] C. Heldin,et al. Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer* , 1998, The Journal of Biological Chemistry.
[24] J. D. Brown,et al. CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] K. Miyazono,et al. Interplay of signal mediators of decapentaplegic (Dpp): molecular characterization of mothers against dpp, Medea, and daughters against dpp. , 1998, Molecular biology of the cell.
[26] R. Derynck,et al. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. , 1998, Genes & development.
[27] Takeshi Imamura,et al. Smad proteins exist as monomers in vivo and undergo homo‐ and hetero‐oligomerization upon activation by serine/threonine kinase receptors , 1998, The EMBO journal.
[28] T. Hunter,et al. TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. , 1998, Genes & development.
[29] K. Kinzler,et al. Characterization of human FAST-1, a TGFβ and activin signal transducer , 1998 .
[30] P. Hoodless,et al. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. , 1998, Molecular cell.
[31] A. Moustakas,et al. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[32] Denis Vivien,et al. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.
[33] P. P. Hu,et al. Molecular Mechanisms of Transforming Growth Factor-β Signaling , 1998 .
[34] J. Hudson,et al. The Drosophila Medea gene is required downstream of dpp and encodes a functional homolog of human Smad4. , 1998, Development.
[35] R. W. Padgett,et al. The Drosophila gene Medea demonstrates the requirement for different classes of Smads in dpp signaling. , 1998, Development.
[36] L. Dobens,et al. Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses. , 1998, Development.
[37] J. Wrana,et al. Mads and Smads in TGFβ signalling , 1998 .
[38] R. White,et al. Tumor Suppressing Pathways , 1998, Cell.
[39] K. Kinzler,et al. Human Smad3 and Smad4 are sequence-specific transcription activators. , 1998, Molecular cell.
[40] A. Roberts. Molecular and Cell Biology of TGF-β , 1998, Mineral and Electrolyte Metabolism.
[41] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[42] J. Massagué,et al. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. , 1997, Genes & development.
[43] Jeffrey L. Wrana,et al. TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling* , 1997, The Journal of Biological Chemistry.
[44] C. Wernstedt,et al. Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-β Signaling* , 1997, The Journal of Biological Chemistry.
[45] R. Derynck,et al. TGF- receptor signaling , 1997 .
[46] Minoru Watanabe,et al. Smad4 and FAST-1 in the assembly of activin-responsive factor , 1997, Nature.
[47] Takeshi Imamura,et al. TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4 , 1997 .
[48] Wei Hu,et al. Sp1 Is Required for the Early Response of α2(I) Collagen to Transforming Growth Factor-β1* , 1997, The Journal of Biological Chemistry.
[49] Kirby D. Johnson,et al. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic , 1997, Nature.
[50] J. Massagué,et al. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 , 1997, Nature.
[51] Yigong Shi,et al. A structural basis for mutational inactivation of the tumour suppressor Smad4 , 1997, Nature.
[52] K. Kinzler,et al. Frequency of Smad gene mutations in human cancers. , 1997, Cancer research.
[53] T. Musci,et al. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function , 1997, Current Biology.
[54] P. P. Hu,et al. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B , 1997, Molecular and cellular biology.
[55] J. Massagué,et al. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. , 1997, Genes & development.
[56] P. Hoodless,et al. MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling , 1996, Cell.
[57] M. Centrella,et al. Cloning, characterization, and expression of the transforming growth factor‐β type I receptor promoter in fetal rat bone cells , 1996, Journal of cellular biochemistry.
[58] J. Massagué,et al. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.
[59] Xin Chen,et al. A transcriptional partner for MAD proteins in TGF-β signalling , 1996, Nature.
[60] S. Kern,et al. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. , 1996, Cancer research.
[61] R. Derynck,et al. Receptor-associated Mad homologues synergize as effectors of the TGF-β response , 1996, Nature.
[62] Irene L Andrulis,et al. MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.
[63] A. Fine,et al. Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-β receptor: regulation by TGF-β , 1996 .
[64] J. Massagué,et al. A human Mad protein acting as a BMP-regulated transcriptional activator , 1996, Nature.
[65] Kathleen R. Cho,et al. DPC4 gene in various tumor types. , 1996, Cancer research.
[66] R. Derynck,et al. Ligand-independent Activation of Transforming Growth Factor (TGF) β Signaling Pathways by Heteromeric Cytoplasmic Domains of TGF-β Receptors* , 1996, The Journal of Biological Chemistry.
[67] C. Moskaluk,et al. Homozygous deletion map at 18q21.1 in pancreatic cancer. , 1996, Cancer research.
[68] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[69] M. Sporn,et al. Characterization of the Promoter Region of the Human Transforming Growth Factor-β Type II Receptor Gene * , 1995, The Journal of Biological Chemistry.
[70] Jian-ming Li,et al. Transforming Growth Factor β Activates the Promoter of Cyclin-dependent Kinase Inhibitor p15INK4B through an Sp1 Consensus Site (*) , 1995, The Journal of Biological Chemistry.
[71] R. Derynck,et al. Transforming Growth Factor-β (TGF-β)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-β Receptor Complex , 1995, The Journal of Biological Chemistry.
[72] A. Iavarone,et al. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. , 1995, Genes & development.
[73] Xiao-Fan Wang,et al. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[74] J. Little,et al. Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect (*) , 1995, The Journal of Biological Chemistry.
[75] A. Fine,et al. Structure and Expression of the Promoter for the Human Type II Transforming Growth Factor-β Receptor , 1994 .
[76] Gregory J. Hannon,et al. pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.
[77] Jeffrey L. Wrana,et al. Mechanism of activation of the TGF-β receptor , 1994, Nature.
[78] M. Sporn,et al. Regulation of the transforming growth factor-β1 and -β3 promoters by transcription factor Spl , 1993 .
[79] J. Massagué,et al. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. , 1990, The Journal of biological chemistry.
[80] R. Derynck,et al. Human Transforming Growth Factor- β3: Recombinant Expression, Purification, and Biological Activities in Comparison with Transforming Growth Factors-β 1 and -β2 , 1989 .
[81] M. Sporn,et al. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. , 1989, The Journal of biological chemistry.
[82] R. Tjian,et al. Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.
[83] M. Sporn,et al. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. , 1988, The Journal of biological chemistry.
[84] J. Wrana,et al. The Drosophila activin receptor baboon signals through dSmad2 and controls cell proliferation but not patterning during larval development. , 1999, Genes & development.
[85] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[86] R. Derynck,et al. Smads: transcriptional activators of TGF-beta responses. , 1998, Cell.
[87] J. Waxman. Molecular endocrinology of cancer , 1996 .
[88] 한평림. A Transcriptional Partner for MAD Proteins in TGF - b Signalling , 1996 .
[89] M. Sporn,et al. Transforming growth factor-beta s in mammary tumorigenesis: promoters or antipromoters? , 1995, Progress in clinical and biological research.
[90] R. Derynck,et al. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. , 1995, The Journal of biological chemistry.
[91] M. Sporn,et al. Molecular cloning and structure of the human transforming growth factor-beta 2 gene promoter. , 1991, Growth factors.
[92] R. Tjian,et al. Multiple specific contacts between a mammalian transcription factor and its cognate promoters , 1984, Nature.